Global Good to commercialize vaccine storage invention for use in developing countries

   Global Good and AUCMA announced an agreement to commercialize Global Good’s vaccine storage invention for use in developing countries. Under the agreement, AUCMA, described as a leading refrigeration company, “will manufacture and distribute the device to help strengthen the vaccine supply chain in underserved regions. The agreement marks the first commercialization deal for Global Good, which is a collaboration between Intellectual Ventures (IV) and Bill Gates to invent technology that improves life in developing countries.” Global Good’s vaccine storage device uses “a combination of super-insulation techniques to hold vaccines at the appropriate temperature for more than a month with no external power. Originally unveiled by IV CEO Nathan Myhrvold at TED 2010, the device was developed at IV Lab and recently completed field trials in Senegal.” The vaccine storage device will undergo additional field testing in Africa before broader manufacturing and distribution in 2014. “With only a single batch of ice, it can store up to 300 doses of vaccines, enough to serve a community of 6,000 for more than a month. The device is also equipped with technology to monitor its location, internal temperature and the number of times vaccines have been retrieved from it. This information can be communicated via daily SMS transmissions and downloaded via a USB port to inform future vaccination campaign planning.”

Full Media Release: BELLEVUE, Wash. and QINGDAO, China, July 9, 2013 /PRNewswire/ http://www.prnewswire.com/news-releases/global-good-and-aucma-partner-to-commercialize-vaccine-storage-invention-for-developing-countries-214733141.html